Work

MA08.06 Comparison of Asandeutertinib and Osimertinib in EGFR-Mutated NSCLC With Brain Metastases: Interim Analysis of the ESAONA Pivotal Study

Year: 2025

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.162

Authors: Y. Shi, L. Xing, Z. Zhang, L. Wu, W. Zhuang, X. Li, Y. Cheng, W. Yang, Y. Yu, Z. Zhang, J. He, P. Zhang, J. Li, Y. Luo, L. Sun, L. Wu, J. Mu, C. Li, X. Chen, Y. Wu

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Shandong Tumor Hospital, First Affiliated Hospital of Henan University of Science and Technology, Central South University, First Affiliated Hospital of Gannan Medical University, Fujian Provincial Cancer Hospital, Zhengzhou University, First Affiliated Hospital of Zhengzhou University, Jilin Province Tumor Hospital, Shanxi Provincial Cancer Hospital, Harbin Medical University, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, Tongji University, Shanghai Pulmonary Hospital, Hunan Cancer Hospital, First Affiliated Hospital of Nanchang University, TYK Medicines, Inc.

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415519271

Cites:

Cited by: 2

Related to: 10